Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2425 participants.
Also called NCT03790800
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,425 participants
- Sponsor
- Registry
-
NCT03790800
-
- Other papers using this trial's data
- Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03790800. Randomized; single masking; primary purpose treatment. Start 2020-03-20 (actual); primary completion 2023-11-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
- Acronym
- INTERACT4
- Condition
- Stroke, Acute
- Condition
- Cerebrovascular Disorders
- Intervention (Drug)
- urapidil
- Lead sponsor
- The George Institute for Global Health, China
- Collaborator
- Shanghai East Hospital
- Collaborator
- First Affiliated Hospital of Chengdu Medical College
- Collaborator
- Sichuan Academy of Medical Sciences
Record details
- Record id
cardio:ct-nct03790800- Content hash
dd34badd4e6916ee5032a847dfe1503e968126e828946e1503748d65f48ffb22